Home・Elenco Azioni・Cogent Biosciences Inc

Cogent Biosciences Inc

Chiusa

38.8 -6.48

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

38.67

Massimo

39.32

Metriche Chiave
By Trading Economics
Entrata	5.1M -97M
EPS	-0.53
Dipendenti	258
EBITDA	14M -95M

Raccomandazioni
By TipRanks
Raccomandazioni	Fortemente da comprare
Previsioni per 12 mesi	+34.68% upside

Dividendi
By Acuity
Utili prossimi	4 ago 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	636M 6.9B
Apertura precedente	45.28
Chiusura precedente	38.8

Cogent Biosciences Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

1 ago 2026, 23:51 UTC

Correlated Moves

Bitcoin is trading lower, reflecting a cumulative decline since Friday. The asset is approximately 2.53% below its 20-day moving average.

1 ago 2026, 23:01 UTC

The Nikkei 225 Index is trading lower during after-market hours, reflecting a decline from earlier highs and remaining near the lower end of its one-month range.

1 ago 2026, 20:01 UTC

Oil (Brent) is trading higher in after-market hours, reflecting strong momentum and remaining above its 20-day moving average. No specific news was identified.

1 ago 2026, 20:01 UTC

Correlated Moves

Silver is trading lower in after-market hours, reflecting weakness since Friday's close. The price is near the lower end of its one-month range.

1 ago 2026, 20:01 UTC

The DAX 30 Index is trading lower in after-market hours, reversing earlier gains and closing below Friday's level. No specific news was identified.

1 ago 2026, 20:01 UTC

Correlated Moves

Gold prices are lower during after-market hours, reflecting unusual price action near the lower end of its one-month range. Silver also declined in tandem.

1 ago 2026, 19:11 UTC

Correlated Moves

Avalanche is trading lower during Saturday's session amid a broader cryptocurrency market downturn, with Bitcoin also declining and the asset below its 20-day moving average.

1 ago 2026, 19:01 UTC

News

Correlated Moves

Ethereum is trading lower, reflecting a broader decline in correlated assets. It remains below its 20-day moving average amid routine market fluctuations.

1 ago 2026, 18:51 UTC

Cardano is trading higher during Saturday's session, reflecting a cumulative gain since Friday. The asset remains above its 20-day moving average.

1 ago 2026, 18:41 UTC

Correlated Moves

Ethereum is trading lower today, influenced by declines in Bitcoin. The asset remains near the upper end of its one-month range.

1 ago 2026, 18:01 UTC

The Nasdaq 100 Index is lower during after-market hours, declining since Friday's close and trading near the lower end of its one-month range.

1 ago 2026, 11:52 UTC

Fed Chair Kevin Warsh's Upcoming Speech Sparks Market Speculation on Interest Rate Changes Amid Rising Inflation Concerns.

1 ago 2026, 11:52 UTC

U.S. Nonfarm Productivity Expected to Rise 0.7% in Q2 2026 Amid Mixed Economic Signals

1 ago 2026, 11:52 UTC

U.S. Unit Labour Costs Set to Rise 2.7% Amid Strong Wage Growth, Heightening Inflation Concerns Ahead of Federal Reserve Policy Decisions

1 ago 2026, 11:51 UTC

Swiss markets closed for National Day; Bitcoin and Ethereum see slight gains, while concerns grow over U.S. stock market reliance on AI-driven stocks and potential Japanese Yen interventions.

1 ago 2026, 11:51 UTC

"Bitcoin and Ethereum see gains amid speculation, while U.S. Dollar dips as traders eye key economic data and potential Fed policy shifts."

1 ago 2026, 11:51 UTC

Bitcoin and Ethereum see modest gains amid economic uncertainties, while U.S. stock market concentration raises investor concerns and key labor data looms ahead.

1 ago 2026, 11:51 UTC

Swiss markets closed for National Day; U.S. stocks rally amid inflation concerns and upcoming key labor data.

1 ago 2026, 11:41 UTC

Mexico's Inflation Rate Release on August 7, 2026 Expected to Show Continued Easing Amid Global Trends.

1 ago 2026, 11:41 UTC

U.S. Mortgage Rates Hit One-Year High at 6.66%, Raising Concerns Over Homebuying Demand Ahead of MBA Release on August 5

1 ago 2026, 11:41 UTC

Mexico's Inflation Rate Release on August 7, 2026: Market Anticipates Impact on Economic Policy Amid Mixed Sentiment and External Risks.

1 ago 2026, 11:31 UTC

U.S. Exports Data Release on August 4, 2026, Sparks Caution Amid Economic Slowdown and Global Trade Tensions

1 ago 2026, 11:31 UTC

U.S. Trade Deficit Expected to Widen to -$73 Billion Amid Rising Imports and Geopolitical Tensions

1 ago 2026, 11:22 UTC

U.S. Imports Data Release on August 4 Expected to Show Continued Growth Amid Tariff Distortions and Global Trade Dynamics

1 ago 2026, 11:22 UTC

Canada's Balance of Trade expected to show C$3.0 billion surplus amid mixed economic sentiment and external challenges on August 4, 2026.

1 ago 2026, 11:22 UTC

Market anticipates 75K job increase in upcoming ADP Employment Change report amid mixed economic signals and cautious optimism.

1 ago 2026, 11:02 UTC

Japan's Upcoming Household Spending Report Signals Consumer Caution Amid Mixed Economic Indicators and Retail Disappointment.

1 ago 2026, 11:02 UTC

Japan's Household Spending Expected to Rise 0.9% Amid Inflation Concerns and Yen Volatility Ahead of August Release

1 ago 2026, 10:51 UTC

Brazil's Central Bank Faces Pressure on SELIC Rate Decision Amid Inflation and Economic Stability Concerns Ahead of August 5th Announcement.

1 ago 2026, 10:51 UTC

Mexican Consumer Confidence Index Set for Release Amid Cautious Optimism and Mixed Economic Sentiment on August 4, 2026.

Confronto tra pari

Modifica del prezzo

Cogent Biosciences Inc Previsione

Obiettivo di Prezzo

By TipRanks

34.68% in crescita

Previsioni per 12 mesi

Media 52.43 USD 34.68%

Alto 60 USD

Basso 45 USD

Basato su 9 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Cogent Biosciences Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

9 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 9 che hanno fornito valutazioni azionarie a Cogent Biosciences Inc - Dist negli ultimi 3 mesi.

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo Cogent Biosciences Inc

Cogent Biosciences, Inc., a biotechnology company, focuses on developing precision therapies for genetically defined diseases. Its lead product candidate includes bezuclastinib (CGT9486), a selective tyrosine kinase inhibitor designed to target mutations within the KIT receptor tyrosine kinase, including KIT D816V KIT D816V mutation that drives systemic mastocytosis, as well as other mutations in KIT exon 17, which are found in patients with advanced gastrointestinal stromal tumors. The company has a licensing agreement with Plexxikon Inc. for the research, development, and commercialization of bezuclastinib. The company was formerly known as Unum Therapeutics Inc. and changed its name to Cogent Biosciences, Inc. in October 2020. Cogent Biosciences, Inc. was incorporated in 2014 and is headquartered in Waltham, Massachusetts.